TL;DR: The Centers for Medicare & Medicaid Services modified NCD 225, the National Coverage Determination governing Medicare coverage of pneumatic compression devices, effective March 7, 2026. Here's what billing teams need to know before submitting claims.
This update to the CMS pneumatic compression device coverage policy clarifies the medical necessity criteria, conservative therapy trial requirements, and device-type distinctions that determine whether a claim pays or gets denied. The policy does not list specific CPT or HCPCS codes in the version data available — HCPCS code E0652 is referenced in the policy narrative for segmented, calibrated gradient devices. Review your charge capture and documentation protocols now, before the effective date of March 7, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Pneumatic Compression Devices — NCD 225 |
| Policy Code | NCD 225 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | High |
| Specialties Affected | Vascular surgery, wound care, lymphedema therapy, physical therapy, DME suppliers |
| Key Action | Audit documentation for conservative therapy trials before submitting claims under NCD 225 |
CMS Pneumatic Compression Device Coverage Criteria and Medical Necessity Requirements 2026
NCD 225 is the National Coverage Determination governing Medicare coverage of pneumatic compression devices for home use. CMS covers these devices under the durable medical equipment benefit category — but only for two specific indications, and only when strict medical necessity criteria are met.
The two covered indications are lymphedema and chronic venous insufficiency (CVI) with venous stasis ulcers. Everything else is not covered. That's a narrow window, and CMS spells out exactly what you need to document before a device goes home with a patient.
Lymphedema Coverage Criteria
For lymphedema, the patient must complete a four-week trial of conservative therapy before pneumatic compression device coverage kicks in. The treating physician must then determine that there has been no significant improvement — or that significant symptoms remain — after that trial.
The four-week trial is not optional. It must include all three of the following:
| # | Covered Indication |
|---|---|
| 1 | An appropriate compression bandage system or compression garment (prefabricated or custom-fabricated, with adequate graduated compression) |
| 2 | Exercise |
| 3 | Elevation of the limb |
If your documentation doesn't show all three components of the conservative therapy trial, expect a claim denial. CMS auditors look for this specifically.
Chronic Venous Insufficiency Coverage Criteria
For CVI, the bar is higher. The patient must have one or more venous stasis ulcers that have failed to heal after a six-month trial of conservative therapy directed by the treating physician.
That six-month trial must include:
| # | Covered Indication |
|---|---|
| 1 | A compression bandage system or compression garment |
| 2 | Appropriate wound dressings |
| 3 | Exercise |
| 4 | Elevation of the limb |
Six months is a long time. Make sure the medical record shows the full timeline, including wound measurements and dressing changes, before the physician prescribes the device.
General Medical Necessity Requirements
Regardless of indication, CMS requires physician oversight throughout the entire process. The treating physician must evaluate the patient's condition, confirm medical necessity, instruct the patient on device operation, define a treatment plan with specific pressure settings and frequency/duration of use, and monitor the patient's ongoing response.
The medical necessity determination itself must include four elements:
| # | Covered Indication |
|---|---|
| 1 | The patient's diagnosis and prognosis |
| 2 | Symptoms and objective findings, including measurements that establish severity |
| 3 | The reason the device is required, including treatments tried and failed |
| 4 | The clinical response to an initial treatment session with the device |
That fourth element matters more than most billing teams realize. The clinical response includes the change in pre-treatment measurements, the patient's ability to tolerate the treatment session, and the patient's (or caregiver's) ability to apply the device at home. If the initial treatment response isn't documented, the claim is exposed.
Prior Authorization and Physician Prescription Requirements
The coverage policy requires a physician prescription — this device is not covered without one. Prior authorization is not explicitly called out in NCD 225 itself, but your Medicare Administrative Contractor may impose additional requirements at the local level through a local coverage determination (LCD). Check with your MAC before assuming NCD 225 alone governs your claims.
This is especially true for DME suppliers billing for these devices in the home setting. Reimbursement depends on meeting both the national and any applicable local criteria.
CMS Pneumatic Compression Device Exclusions and Non-Covered Indications
CMS covers pneumatic compression devices only for lymphedema and CVI with venous stasis ulcers. Any other indication is not covered under this policy.
The policy also draws a sharp line around device type. HCPCS code E0652 — the segmented, calibrated gradient pneumatic compression device — is only covered in specific circumstances. The policy narrative indicates this device type has a higher coverage threshold than standard devices. If you're billing E0652, confirm that your documentation supports the distinct criteria for that device type, not just the general lymphedema or CVI criteria.
Devices that don't meet the physician oversight requirements — prescription, treatment plan, initial clinical response documentation — are not covered regardless of the patient's diagnosis.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Lymphedema (with failed 4-week conservative therapy trial) | Covered | E0652 (segmented gradient device, specific criteria apply) | Must include compression garment/bandage, exercise, and limb elevation in trial |
| Chronic venous insufficiency with venous stasis ulcers (failed 6-month conservative therapy trial) | Covered | — | Trial must include compression, wound dressings, exercise, and limb elevation |
| Segmented, calibrated gradient pneumatic compression device (E0652) | Covered (restricted) | E0652 | Only covered under specific circumstances per policy narrative — higher documentation threshold |
| Pneumatic compression devices without physician prescription | Not Covered | — | Prescription required; no exceptions |
| Pneumatic compression devices without documented physician oversight and treatment plan | Not Covered | — | Pressure settings, frequency, duration must be defined in writing |
| Any indication other than lymphedema or CVI with venous stasis ulcers | Not Covered | — | NCD 225 does not extend to other edema conditions or indications |
CMS Pneumatic Compression Device Billing Guidelines and Action Items 2026
This policy change has real financial exposure for DME suppliers, wound care programs, and any practice that prescribes these devices for home use. Here's what to do before March 7, 2026.
| # | Action Item |
|---|---|
| 1 | Audit your documentation templates for the conservative therapy trial. For lymphedema claims, your intake documentation must capture all three trial components — compression garment, exercise, and limb elevation — across a minimum four-week period. For CVI claims, that window extends to six months with wound dressing documentation added. If your templates don't capture these elements explicitly, update them now. |
| 2 | Verify physician oversight documentation on every active order. Pull a sample of recent claims and confirm that each file includes: a written prescription, a treatment plan with specific pressure and usage parameters, documentation of the initial clinical response session (including pre-treatment measurements), and evidence of ongoing monitoring. Missing any of these elements puts the claim at risk. |
| 3 | Confirm your MAC's local coverage determination requirements. NCD 225 sets the national floor, but your Medicare Administrative Contractor may have an LCD with additional criteria or prior authorization requirements for pneumatic compression devices. Check your MAC's website or call their provider line before the effective date. |
| 4 | Apply extra scrutiny to E0652 claims. The policy singles out the segmented, calibrated gradient pneumatic compression device (HCPCS E0652) as having distinct — and more restrictive — coverage criteria. If your team bills E0652, confirm that your clinical staff understands the specific threshold for that code and that documentation reflects it. Generic lymphedema documentation won't hold up for E0652 if the device type carries a higher bar. |
| 5 | Brief your prescribing physicians on the four-part medical necessity documentation requirement. The treating physician carries the documentation burden under NCD 225. Make sure your physicians know they need to record the patient's diagnosis and prognosis, objective severity measurements, the treatment history showing prior failure, and the clinical response to the initial device session — in writing, in the medical record. A verbal order and a diagnosis code is not enough. |
| 6 | Review your charge capture for pneumatic compression device billing. If your system is set up to auto-populate claims without triggering a documentation checklist, that's a gap. Build a pre-claim audit step into your workflow that flags pneumatic compression device claims for documentation review before submission. |
If you're billing a significant volume of these claims and you're not confident your documentation protocols cover the NCD 225 criteria, loop in your compliance officer before the March 7, 2026 effective date. The conservative therapy trial requirements alone generate a significant share of claim denials on these devices.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Pneumatic Compression Devices Under NCD 225
The policy data available for NCD 225 in the March 7, 2026 update does not include a complete code list. The policy narrative references one HCPCS code directly.
HCPCS Codes Referenced in NCD 225 Policy Narrative
| Code | Type | Description |
|---|---|---|
| E0652 | HCPCS | Segmented, calibrated gradient pneumatic compression device — covered only under specific criteria per NCD 225 |
Note: The NCD 225 policy data does not include additional CPT, HCPCS, or ICD-10 codes in this version. Your MAC's local coverage determination for pneumatic compression devices will likely carry a more complete code list — including standard device codes and applicable ICD-10-CM diagnosis codes for lymphedema and chronic venous insufficiency. Pull that LCD and cross-reference it against this NCD before submitting claims.
Do not assume that codes not listed in this policy are automatically excluded. The absence of a code list in NCD 225 means you need to verify at the local level.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.